Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Osteoporosis, Osteopenia
Interventions: DRUG: Vivomixx|DRUG: Placebo
Sponsor: Tel-Aviv Sourasky Medical Center
Collaborators: Perrigo Company